Merck & Co., Inc.
RAHWAY NJ · SEC CIK 0000310158
$3.49亿2026Q1 申报市值
14持仓数
99.7%前十大占比 · 第一大 33.6%
3 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
EIKN 新建仓+$1,763.33万
AKTS 新建仓+$1,704.64万
XILIO THERAPEUTI 新建仓+$89.13万
TUHURA BIOSCIENC 加仓+$9,836
2026Q1 卖出最多 按季末市值估算
XILIO THERAPEUTI 清仓-$94.99万
2026Q1 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▲ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| — | XILIO THERAPEUTICS INC | $0 | 0.00% | 0 | -1,483,758 | -100.0% | -$94.99万 | 清仓 |
| — | TUHURA BIOSCIENCES | $3.48万 | 0.01% | 19,445 | 5,495 | 39.4% | $9,836 | 加仓 |
| — | NEUPHORIA THERAPEUTICS INC | $4.08万 | 0.01% | 10,027 | 0 | 0.0% | — | 不变 |
| — | CARISMA THERAPEUTICS INC | $4.79万 | 0.01% | 1,473,240 | 0 | 0.0% | — | 不变 |
| — | XILIO THERAPEUTICS INC | $89.13万 | 0.26% | 105,982 | 105,982 | — | $89.13万 | 新建仓 |
| VRDN | VIRIDIAN THERAPEUTICS INC | $182.72万 | 0.52% | 93,414 | 0 | 0.0% | — | 不变 |
| — | EVAXION BIOTECH A/S | $451.65万 | 1.29% | 1,214,126 | 0 | 0.0% | — | 不变 |
| — | SUTRO BIOPHARMA INC | $678.43万 | 1.94% | 272,351 | 0 | 0.0% | — | 不变 |
| ALEC | ALECTOR INC | $762.33万 | 2.18% | 3,545,719 | 0 | 0.0% | — | 不变 |
| AKTS | AKTIS ONCOLOGY INC | $1,704.64万 | 4.88% | 952,844 | 952,844 | — | $1,704.64万 | 新建仓 |
| EIKN | EIKON THERAPEUTICS INC | $1,763.33万 | 5.05% | 1,666,666 | 1,666,666 | — | $1,763.33万 | 新建仓 |
| — | ENTRADA THERAPEUTICS INC | $2,195.59万 | 6.28% | 1,739,768 | 0 | 0.0% | — | 不变 |
| KYMR | KYMERA THERAPEUTICS INC | $6,431.36万 | 18.40% | 772,165 | 0 | 0.0% | — | 不变 |
| PSNL | PERSONALIS INC | $8,946.63万 | 25.60% | 14,044,943 | 0 | 0.0% | — | 不变 |
| MRNA | MODERNA INC | $1.17亿 | 33.56% | 2,308,190 | 0 | 0.0% | — | 不变 |